JNJ Johnson & Johnson Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

JNJ [NYSE]

Johnson & Johnson

Healthcare | Drug Manufacturers - General | USA

statements

Index	DJIA S&P500	P/E	23.24	EPS (ttm)	6.25	Insider Own	0.08%	Shs Outstand	2.63B	Perf Week	-1.93%
Market Cap	381.97B	Forward P/E	16.14	EPS next Y	9.00	Insider Trans	-2.02%	Shs Float	2.63B	Perf Month	0.39%
Income	16.69B	PEG	5.37	EPS next Q	1.83	Inst Own	70.20%	Short Float	0.44%	Perf Quarter	-1.32%
Sales	80.86B	P/S	4.72	EPS this Y	0.50%	Inst Trans	-0.07%	Short Ratio	1.93	Perf Half Y	-5.87%
Book/sh	24.49	P/B	5.93	EPS next Y	12.42%	ROA	9.50%	Target Price	166.18	Perf Year	13.91%
Cash/sh	11.70	P/C	12.41	EPS next 5Y	4.33%	ROE	24.50%	52W Range	109.16 - 157.00	Perf YTD	-0.43%
Dividend	4.04	P/FCF	52.47	EPS past 5Y	-0.20%	ROI	17.30%	52W High	-7.49%	Beta	0.66
Dividend %	2.78%	Quick Ratio	1.20	Sales past 5Y	2.00%	Gross Margin	65.80%	52W Low	33.05%	ATR	2.53
Employees	132200	Current Ratio	1.50	Sales Q/Q	1.70%	Oper. Margin	20.20%	RSI (14)	43.50	Volatility	1.78% 1.56%
Optionable	Yes	Debt/Eq	0.59	EPS Q/Q	102.70%	Profit Margin	18.80%	Rel Volume	0.69	Prev Close	145.08
Shortable	Yes	LT Debt/Eq	0.51	Earnings	Oct 13 BMO	Payout	66.90%	Avg Volume	5.94M	Price	145.24
Recom	1.90	SMA20	-1.40%	SMA50	-2.23%	SMA200	-0.11%	Volume	4,154,372	Change	0.11%

Apr-28-20

Downgrade

UBS

Buy → Neutral

$163 → $160

Apr-22-20

Upgrade

BofA/Merrill

Neutral → Buy

$150 → $175

Mar-05-20

Initiated

Citigroup

Buy

$163

Dec-19-19

Upgrade

Barclays

Equal Weight → Overweight

$173

Dec-17-19

Upgrade

Morgan Stanley

Equal-Weight → Overweight

$145 → $170

Nov-20-19

Initiated

Cantor Fitzgerald

Overweight

$160

Oct-16-19

Upgrade

Atlantic Equities

Underweight → Neutral

Oct-11-19

Upgrade

Bernstein

Mkt Perform → Outperform

$155

Jul-12-19

Resumed

Credit Suisse

Outperform

$156

May-28-19

Initiated

Goldman

Buy

Jan-23-19

Reiterated

Barclays

Equal Weight

$137 → $135

Jul-12-18

Upgrade

Goldman

Sell → Neutral

Jun-27-18

Initiated

Bernstein

Mkt Perform

$129

Apr-23-18

Reiterated

Citigroup

Neutral

$146 → $134

Apr-18-18

Reiterated

Stifel

Hold

$145 → $135

Jan-24-18

Reiterated

Stifel

Hold

$142 → $145

Jan-12-18

Reiterated

Wells Fargo

Outperform

$155 → $160

Jan-02-18

Downgrade

JP Morgan

Overweight → Neutral

Oct-18-17

Reiterated

Stifel

Hold

$140 → $142

Oct-18-17

Reiterated

RBC Capital Mkts

Outperform

$144 → $147

Oct-25-20 02:33PM	What Are the Differences Between the Leading Coronavirus Vaccine Candidates? Motley Fool
11:32AM	3 Coronavirus Vaccine Stocks That Especially Stand Out Right Now Motley Fool
06:25AM	American Express Hit With 40% Profit Slump; Shares Fall 3.6% SmarterAnalyst
Oct-24-20 08:00AM	Whirlpool and 3 Other Companies That Raised Their Dividends This Week Barrons.com
06:45AM	Are Consumers and Investors Protected Against COVID-19 Vaccine Risks? Motley Fool
06:17AM	5 Great Stocks You Can Buy and Hold Forever Motley Fool
Oct-23-20 11:09PM	AstraZeneca resumes U.S. COVID-19 vaccine trial and next week J&J prepares to do same Reuters
04:57PM	Is Kimberly-Clark's Pullback an Opportunity to Buy? GuruFocus.com
04:52PM	Johnson & Johnson Covid-19 Vaccine Trial Set to Resume TheStreet.com
04:52PM	J&J to resume U.S. part of COVID-19 vaccine clinical trial MarketWatch
04:33PM	Remdesivir is not a knock out punch but it does help patients recover quicker: doctor Yahoo Finance Video
04:25PM	Johnson & Johnson stock rises Friday, still underperforms market MarketWatch
04:17PM	J&J preparing to resume U.S. trial of COVID-19 vaccine candidate Reuters
03:54PM	WRAPUP 8-AstraZeneca resumes U.S. COVID-19 vaccine trial and next week J&J prepares to do same Reuters
03:30PM	Pharmaceutical companies are doing a good job with efficacy and transparency: physician Yahoo Finance Video
11:33AM	Coronavirus update: US sets new daily case record; FDA approves Gilead's remdesivir Yahoo Finance
10:05AM	Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus Zacks
09:44AM	COVID-19 'Pool testing' in schools would give insight on how well masks in schools are doing: Dr. Dara Kass Yahoo Finance Video
Oct-22-20 04:51PM	US faces major hurdles for COVID-19 vaccine distribution: Vaccine advisory committee Yahoo Finance
04:28PM	Moderna Covid-19 Vaccine Nears; Passes Key Milestone In Final Testing Investor's Business Daily
04:25PM	Johnson & Johnson stock outperforms market on strong trading day MarketWatch
03:34PM	Coronavirus Latest: Thursday, October 22 Yahoo Finance Video
02:16PM	Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2020 PR Newswire
01:59PM	FDA Covid Meeting Shows the Companies Behind the Vaccines Barrons.com
01:43PM	Pfizer, Moderna Vaccines, Gilead Treatment In Focus As Health Firms Report Q3 Earnings Benzinga
12:48PM	JNJ Stock: Break Of Support Presents Bearish Option Trade Investor's Business Daily
12:44PM	Pfizer, J&J urge clarity from FDA on future of COVID-19 vaccine trials once a vaccine is available Reuters
12:04PM	Glaxo Vaccines Target Another Viral Threat Barrons.com
10:37AM	AstraZeneca (AZN), J&J (JNJ) Coronavirus Trials May Resume Soon Zacks
10:19AM	What to expect from the FDA's COVID-19 vaccine meeting today Yahoo Finance Video
10:15AM	Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus Zacks
09:00AM	Intuitive Surgical Says Outlook Still Murky Is ISRG Stock A Buy? Investor's Business Daily
Oct-21-20 04:34PM	Coronavirus Latest: Wednesday, October 21 Yahoo Finance Video
04:25PM	Johnson & Johnson stock falls Wednesday, underperforms market MarketWatch
12:14PM	2 Late-Stage Coronavirus Vaccine Candidates in Limbo Motley Fool
12:05PM	Dow Stutters as Traders Continue to Sweat on Stimulus Progress Investing.com
Oct-20-20 04:26PM	Johnson & Johnson stock rises Tuesday, still underperforms market MarketWatch
03:49PM	Coronavirus Latest: Tuesday, October 20 Yahoo Finance Video
02:11PM	Covid-19 Vaccines Could Take a Critical Next Step in November Just Not In Time for the Election Barrons.com
11:28AM	Were Hedge Funds Right About Piling Into Johnson & Johnson (JNJ)? Insider Monkey
10:12AM	Moderna's COVID-19 vaccine timeline Yahoo Finance Video
06:30AM	Now Is the Time to Go All-In on These 3 Breakout Stocks Motley Fool
Oct-19-20 04:51PM	Stock Market Today: Investors Lose Their Nerve as Relief Deadline Nears Kiplinger
04:32PM	The most difficult phase of the epidemic is ahead of us: doctor Yahoo Finance Video
04:25PM	Johnson & Johnson stock falls Monday, underperforms market MarketWatch
02:40PM	'Not just him': What Trump's antibody use says about the future of coronavirus treatments Yahoo Finance
12:05PM	2 Stocks to Supplement Your Social Security Income Motley Fool
10:01AM	Coronavirus cases surpass 40 million across the globe, 8 million in the U.S. Yahoo Finance Video
Oct-17-20 08:09AM	Better Coronavirus Stock: AstraZeneca or Johnson & Johnson Motley Fool
07:40AM	What You Need to Know at This Stage of the Coronavirus Vaccine Race Motley Fool
Oct-16-20 10:12PM	Jabil Inc. -- Moody's affirms Jabil's Baa3 senior unsecured rating; outlook stable Moody's
06:49PM	Johnson & Johnson -- Moody's assigns Aaa to J&J's sr. notes; outlook negative Moody's
06:07PM	Look Past Covid Vaccine to Johnson & Johnson's Drug Portfolio GuruFocus.com
04:57PM	The market is grappling with what the election means: Darrell Cronk Yahoo Finance Video
04:25PM	Johnson & Johnson stock rises Friday, outperforms market MarketWatch
03:38PM	I think were at the beginning of a third surge of coronavirus: Advancing Health Equity CEO Yahoo Finance Video
03:36PM	Coronavirus Latest: Friday, October 16 Yahoo Finance Video
03:24PM	Misinformation is the 'biggest concern' leading up to election: CrowdStrike President Yahoo Finance Video
01:53PM	Novavax Stock Looks Volatile As Vaccine Enthusiasm Wanes InvestorPlace
01:53PM	Can Cytonics Pivot Successfully to Covid-19 Therapeutics? InvestorPlace
09:57AM	Coronavirus update: Pfizer seeks vaccine authorization in November; Medicare cuts delayed COVID-19 testing payments Yahoo Finance
07:58AM	Biden Town Hall: 4 Key Investing Takeaways InvestorPlace
Oct-15-20 08:05PM	Ignore the Vaccine Noise, Johnson & Johnson Is in Rude Health, Says Top Analyst TipRanks
04:31PM	We need to test smarter by focusing on high-risk populations: doctor Yahoo Finance Video
04:25PM	Johnson & Johnson stock falls Thursday, underperforms market MarketWatch
04:08PM	Eli Lilly Acquisition Expands Efforts To Treat Neurological Diseases Investor's Business Daily
03:19PM	Coronavirus Latest: Thursday, October 15 Yahoo Finance Video
11:59AM	Coronavirus update: CDC eyes small groups as US cases spike; Sanofi announces pre-clinical vaccine data Yahoo Finance
11:31AM	Big Pharma's Vaccine Race A Chance For Redemption Benzinga
10:46AM	The Top 5 Johnson & Johnson Shareholders (JNJ) Investopedia
09:41AM	Coronavirus second wave looms: 'Hope for the best but prepare for the worst' Yahoo Finance
09:00AM	Influencers with Andy Serwer: Richard Davis Yahoo Finance Video
07:33AM	If You Invested $1,000 in Johnson & Johnson in January, This Is How Much You Would Have Today Motley Fool
Oct-14-20 04:59PM	Why Alteryx's Stock Popped Motley Fool
04:44PM	The medical community has learnt a lot and are better prepared for the next phase: doctor Yahoo Finance Video
04:29PM	Coronavirus Latest: Wednesday, October 14 Yahoo Finance Video
04:25PM	Johnson & Johnson stock outperforms market despite losses on the day MarketWatch
04:22PM	Will Covid-19 Vaccine Race Leaders Pfizer, BioNTech Post Initial Phase 3 Data This Week? Investor's Business Daily
03:42PM	'Halftime Report Traders' Share Their Thoughts On Target, Johnson & Johnson And More Benzinga
11:45AM	U.S. puts Eli Lilly's COVID-19 antibody trial on hold due to safety concerns Yahoo Finance Video
11:14AM	How to Invest In Covid-19 Vaccines and Treatments When Trials Keep Getting Paused Barrons.com
09:22AM	Eli Lilly pauses antibody trial over potential safety concern Yahoo Finance Video
08:38AM	There are seven coronavirus vaccine candidates being tested in the U.S. heres where they stand MarketWatch
08:35AM	Got $500? 3 Big Pharma Stocks You Can Buy Now That Pay Dividends Motley Fool
08:23AM	Did You Participate In Any Of Johnson & Johnson's (NYSE:JNJ) Respectable 74% Return? Simply Wall St.
07:57AM	GLOBAL MARKETS-European shares dip on second wave fears Reuters
07:26AM	J&J Offers Up To $5B In US Opioid Addiction Settlement SmarterAnalyst
06:55AM	Better Buy: AbbVie vs. Johnson & Johnson Motley Fool
06:38AM	The Market Needs Some Rest but There Are Many Positives at Work TheStreet.com
01:42AM	GLOBAL MARKETS-Asian equities toppled by stalled vaccine trials, stimulus talks Reuters
Oct-13-20 10:49PM	Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure' over safety concern Reuters
10:21PM	GLOBAL MARKETS-Asian equities slip as vaccine trials, stimulus talks stall Reuters
08:55PM	Gold Up, Boosted by Halted COVID-19 Treatment, U.S. Stimulus Hopes Investing.com
07:33PM	GLOBAL MARKETS-Asian equities set to slip as vaccine trials, stimulus talks stall Reuters
07:01PM	Jim Cramer: Here's How We're Going to Beat Covid-19 TheStreet.com
06:25PM	US Markets Fall as Vaccine Tests are Halted Investopedia
05:32PM	Stocks on the Move: JNJ stocks dip on pausing vaccine trial and Loop Industries stocks down on Hindenburg calling the company's technology "fiction" Yahoo Finance Video
04:49PM	GLOBAL MARKETS-World stocks pause rally on J&J news, dollar bounces from 3-week low Reuters
04:25PM	Johnson & Johnson stock underperforms Tuesday when compared to competitors MarketWatch
04:24PM	Eli Lilly Pauses Covid-19 Treatment Clinical Trials Over Safety Concerns Investor's Business Daily

Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wengel Kathryn E	EVP, Chief GSC Officer	Sep 02	Option Exercise	63.75	16,115	1,027,323	74,535	Sep 04 02:58 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Sep 02	Sale	153.52	16,115	2,473,938	58,420	Sep 04 02:58 PM
McEvoy Ashley	EVP, WW Chair, Medical Devices	Jul 28	Sale	147.47	29,000	4,276,630	21,682	Jul 28 06:43 PM
JOHNSON & JOHNSON	10% Owner	Jun 30	Buy	17.00	725,000	12,325,000	3,670,516	Jul 02 04:58 PM
PEREZ WILLIAM D	Director	Mar 13	Buy	127.69	500	63,843	16,030	Mar 17 04:24 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Feb 21	Option Exercise	90.44	19,224	1,738,619	75,039	Feb 25 04:23 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Feb 21	Sale	147.96	39,224	5,803,583	35,815	Feb 25 04:23 PM
Ullmann Michael H	Exec VP, General Counsel	Feb 13	Option Exercise	0.00	20,326	0	152,697	Feb 18 05:03 PM
Wolk Joseph J	Exec VP, CFO	Feb 13	Option Exercise	0.00	7,080	0	21,387	Feb 18 05:03 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Feb 13	Option Exercise	0.00	15,809	0	65,532	Feb 18 05:03 PM
Fasolo Peter	Exec VP, Chief HR Officer	Feb 13	Option Exercise	0.00	22,231	0	110,559	Feb 18 05:03 PM
Decker Robert J	Controller, CAO	Feb 13	Option Exercise	0.00	1,499	0	13,946	Feb 18 05:03 PM
Duato Joaquin	Vice Chair, Exec Committee	Feb 13	Option Exercise	0.00	105,668	0	220,373	Feb 18 05:03 PM
Gorsky Alex	Chairman, CEO	Feb 13	Option Exercise	0.00	107,016	0	496,472	Feb 18 05:03 PM
McEvoy Ashley	EVP, WW Chair, Medical Devices	Feb 13	Option Exercise	0.00	13,747	0	56,496	Feb 18 05:03 PM
Mongon Thibaut	Exec VP, WW Chair, Consumer	Feb 13	Option Exercise	0.00	3,692	0	57,259	Feb 18 05:03 PM
Sneed Michael E	EVP, Global Corp Aff & COO	Feb 13	Option Exercise	0.00	11,836	0	61,219	Feb 18 05:03 PM
Stoffels Paulus	Vice Chair, Exec Committee	Feb 13	Option Exercise	0.00	39,381	0	270,900	Feb 18 05:03 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 13	Option Exercise	0.00	16,084	0	115,813	Feb 18 05:03 PM
Taubert Jennifer L	EVP, WW Chair, Pharmaceuticals	Feb 03	Option Exercise	0.00	48,312	0	123,450	Feb 04 07:31 PM
McEvoy Ashley	EVP, WW Chair, Medical Devices	Feb 03	Option Exercise	0.00	38,650	0	58,154	Feb 04 07:31 PM
Sneed Michael E	EVP, Global Corp Aff & COO	Jan 30	Option Exercise	62.62	58,128	3,639,975	107,511	Feb 03 06:28 PM
Sneed Michael E	EVP, Global Corp Aff & COO	Jan 30	Sale	149.39	58,128	8,683,568	49,383	Feb 03 06:28 PM
Joly Hubert	Director	Dec 13	Buy	141.28	5,000	706,399	5,000	Dec 16 04:40 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Dec 12	Option Exercise	62.62	2,017	126,305	51,736	Dec 16 05:40 PM
Wengel Kathryn E	EVP, Chief GSC Officer	Dec 12	Sale	141.07	2,017	284,538	49,719	Dec 16 05:40 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience